The revision of the 2014 European tobacco products directive: an analysis of the tobacco industry's attempts to ‘break the health silo’
Open Access
- 24 February 2015
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 25 (1) , 108-117
Abstract
Background The 2014 European Union (EU) Tobacco Products Directive (TPD) was negotiated in a changed policy context, following adoption of the EU's ‘Smart Regulation’ agenda, which transnational tobacco companies (TTCs) anticipated would increase their influence on health policy, and the WHO Framework Convention on Tobacco Control (FCTC), which sought to reduce it. This study aims to explore the scale and nature of the TTCs' lobby against the EU TPD and evaluate how these developments have affected their ability to exert influence. Methods Analysis of 581 documents obtained through freedom of information requests, 28 leaked Philip Morris International (PMI) documents, 17 TTC documents from the Legacy Library, web content via Google alerts and searches of the EU institutions' websites, plus four stakeholder interviews. Results The lobby was massive. PMI alone employed over 160 lobbyists. Strategies mainly used third parties. Efforts to 'Push' (amend) or 'Delay' the proposal and block 'extreme policy options' were partially successful, with plain packaging and point of sales display ban removed during the 3-year delay in the Commission. The Smart Regulation mechanism contributed to changes and delays, facilitating meetings between TTC representatives (including ex-Commission employees) and senior Commission staff. Contrary to Article 5.3, these meetings were not disclosed. Conclusions During the legislative process, Article 5.3 was not consistently applied by non-health Directorates of the European Commission, while the tools of the Smart Regulation appear to have facilitated TTC access to, and influence on, the 2014 TPD. The use of third parties undermines Article 5.3.Keywords
This publication has 15 references indexed in Scilit:
- Representation and Misrepresentation of Scientific Evidence in Contemporary Tobacco Regulation: A Review of Tobacco Industry Submissions to the UK Government Consultation on Standardised PackagingPLOS Medicine, 2014
- Capturing complexity: mixing methods in the analysis of a European tobacco control policy networkInternational Journal of Social Research Methodology, 2014
- A critical evaluation of the volume, relevance and quality of evidence submitted by the tobacco industry to oppose standardised packaging of tobacco productsBMJ Open, 2014
- Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded ‘Project Star’ reportTobacco Control, 2013
- The EU Tobacco Products Directive must not be derailedThe Lancet, 2012
- Health impact assessment in Europe--current dilemmas and challengesEuropean Journal of Public Health, 2012
- Is the increasing policy use of Impact Assessment in Europe likely to undermine efforts to achieve healthy public policy?Journal of Epidemiology and Community Health, 2010
- “Working the System”—British American Tobacco's Influence on the European Union Treaty and Its Implications for Policy: An Analysis of Internal Tobacco Industry DocumentsPLOS Medicine, 2010
- Tobacco industry attempts to undermine Article 5.3 and the “good governance” trap: Table 1Tobacco Control, 2009
- Tobacco industry strategies for influencing European Community tobacco advertising legislationThe Lancet, 2002